1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Human Microbiome Market
2.2. Global Human Microbiome Market, By Product, 2024 (US$ Million)
2.3. Global Human Microbiome Market, By Application, 2024 (US$ Million)
2.4. Global Human Microbiome Market, By Geography, 2024 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2024

3. Human Microbiome Market: Competitive Analysis
3.1. Market Positioning of Key Human Microbiome Market Vendors
3.2. Strategies Adopted by Human Microbiome Market Vendors
3.3. Key Industry Strategies

4. Human Microbiome Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Human Microbiome Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Human Microbiome Market: By Product, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Probiotics
5.3.2. Prebiotics
5.3.3. Medical Foods
5.3.4. Supplements
5.3.5. Others

6. Human Microbiome Market: By Application, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Diagnostics
6.3.2. Therapeutics


7. North America Human Microbiome Market, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Human Microbiome Market: By Product, 2023-2033, USD (Million)
7.3. Human Microbiome Market: By Application, 2023-2033, USD (Million)
7.4.Human Microbiome Market: By Region, 2023-2033, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
7.4.1.1.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
7.4.1.2.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
7.4.1.3.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)

8. UK and European Union Human Microbiome Market, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Human Microbiome Market: By Product, 2023-2033, USD (Million)
8.3. Human Microbiome Market: By Application, 2023-2033, USD (Million)
8.4.Human Microbiome Market: By Region, 2023-2033, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
8.4.1.1.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
8.4.1.2.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
8.4.1.3.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
8.4.1.4.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
8.4.1.5. France
8.4.1.5.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
8.4.1.5.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
8.4.1.6.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)

9. Asia Pacific Human Microbiome Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Human Microbiome Market: By Product, 2023-2033, USD (Million)
9.3. Human Microbiome Market: By Application, 2023-2033, USD (Million)
9.4.Human Microbiome Market: By Region, 2023-2033, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
9.4.1.1.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
9.4.1.2.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
9.4.1.3. India
9.4.1.3.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
9.4.1.3.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
9.4.1.4.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
9.4.1.5.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
9.4.1.6.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)

10. Latin America Human Microbiome Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Human Microbiome Market: By Product, 2023-2033, USD (Million)
10.3. Human Microbiome Market: By Application, 2023-2033, USD (Million)
10.4.Human Microbiome Market: By Region, 2023-2033, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
10.4.1.1.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
10.4.1.2.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
10.4.1.3.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)

11. Middle East and Africa Human Microbiome Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Human Microbiome Market: By Product, 2023-2033, USD (Million)
11.3. Human Microbiome Market: By Application, 2023-2033, USD (Million)
11.4.Human Microbiome Market: By Region, 2023-2033, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
11.4.1.1.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
11.4.1.2.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Human Microbiome Market: By Product, 2023-2033, USD (Million)
11.4.1.3.2. Human Microbiome Market: By Application, 2023-2033, USD (Million)

12. Company Profile
12.1. DuPont
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Enterome Bioscience
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Osel, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Second Genome, Inc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Seres Therapeutics
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Synthetic Biologics, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Synlogic, Inc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Vedanta Biosciences, Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Vithera Pharmaceuticals
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Yakult Honsha Co., Ltd.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives